SANA Sana Biotechnology, Inc.

$3.55

Sana Biotechnology, Inc. (SANA) is expected to report earnings on November 9, 2026, after the market close. The consensus earnings estimate is a loss of $0.17 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -2.7% since its last earnings release on August 10, 2026.

Sana Biotechnology Beat Consensus Estimates
Monday, August 10, 2026 · 4:05 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 9
Monday · 4:05 PM ET
Earnings Whisper
-
vs ($0.17)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $3.67

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Sana Biotechnology, Inc.

Sana Biotechnology Inc. is focused on creating and delivering engineered cells as medicines for patients. The company involved in repairing and controlling genes, replacing missing or damaged cells as well as making its therapies. Sana Biotechnology Inc. is based in SEATTLE.

Sector

Healthcare

Industry

Biotechnology

Held By 1 ETFs, by dollar flow